Overview
Osteoporosis prevalence has increased significantly in recent years and is expected to increase further. One of the prime reasons is the sedentary lifestyle of people. Lack of exercise and activities increases the chances of osteoporosis. Hereditary osteoporosis problem is also a reason for increased prevalence of this disease. There are good chances that children of osteoporosis affected parents will suffer from same problem in future. Consumption of cigarette and alcohol is also a driving factor for osteoporosis disease. Cigarette and alcohol increases the bone deterioration and leads to osteoporosis problem.
The global osteoporosis treatment market was valued at US$ 11.8 Bn in 2017, and is projected to exhibit a CAGR of 3.8% over the forecast period (2018 – 2026).
Global Osteoporosis Treatment Market: Drivers
The global osteoporosis treatment market growth is driven by high prevalence of osteoporosis. For instance, in 2016, around 54 million adult in the U.S were suffering from osteoporosis or have low bone density, according to a report by National Osteoporosis Foundation.
Moreover, approval and launch of new products is also expected to propel growth of the global osteoporosis treatment market over the forecast period. For instance, in 2015, Korea’s Ministry of Food and Drug Safety approved Teribone for the treatment of osteoporosis. The drugs is a joint development of Asahi Kasei Pharma Corporation and Dong-A ST Co. Ltd.
𝐓𝐨 𝐠𝐞𝐭 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 @ https://www.coherentmarketinsights.com/insight/request-sample/1096
Global Osteoporosis Treatment Market: Opportunities
Investment in R&D is expected to offer lucrative growth opportunities for players in the global osteoporosis treatment market. For instance, in May 2018, Pfenex Inc. raised around US$ 39.4 million from public offering for R&D of its novel osteoporosis drug PF708.
Moreover, R&D of new products is also expected to offer lucrative growth opportunities for players in the global osteoporosis treatment market. For instance, in December 2018, Pfenex Inc. submited a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its PF708.
Global Osteoporosis Treatment Market: Restraints
Launch of generic drugs is expected to hinder growth of the global osteoporosis treatment market. For instance, in 2015, Teva Pharmaceutical Industries Ltd. launched generic version of Actonel (risedronate sodium) Tablets, 5 mg, 30 mg, and 35 mg in the U.S. market.
Recent Developments
Major players operating in the global osteoporosis treatment market are focused on adopting partnership strategies to enhance their market share. For instance, in 2014, Asahi Kasei Pharma partnered with Dong-A ST Co. Ltd. granting exclusive development and sale rights of Teribone osteoporosis drug to Dong-A ST Co. Ltd. in South Korea.
Major players operating in the global osteoporosis treatment market are also focused on approval and launch of new products to expand their product portfolio. For instance, in May 2020, Teijin Pharma Limited, a partner of Radius Health, Inc., submitted a New Drug Application for abaloparatide-SC in Japan for the treatment of osteoporosis in patients who are at high risk for fractures.
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅 @ https://www.coherentmarketinsights.com/promo/buynow/1096
Covid-19 Impact Analysis
Globally, as of 5:58pm CET, 15 December 2021, there have been 270,791,973 confirmed cases of COVID-19, including 5,318,216 deaths, reported to WHO. As of 13 December 2021, a total of 8,200,642,671 vaccine doses have been administered. The pandemic has affected the management of many long-term conditions including osteoporosis as resources are diverted to cover urgent care.
Market Trends
Major players operating in the global osteoporosis treatment market are focused on launching new products to enhance their market share. For instance, in 2016, Asahi Kasei Pharma Corporation and Dong-A ST Co. Ltd. launched Teribone for the treatment of osteoporosis in Korea.
Major players operating in the global osteoporosis treatment market are also focused on approval and launch of biosimilars to branded drugs of osteoporosis. For instance, in May 2020, JHL Biotech Inc. randomized and dosed the first group of subjects in the company’s Australian Phase I Clinical Trial of JHL1266, a proposed biosimilar to denosumab, in healthy subjects, in order to evaluate the similarity in pharmacokinetics, pharmacodynamics, and immunogenicity.
Global Osteoporosis Treatment Market: Competitive Landscape
Major players operating in the global osteoporosis treatment market include, Allergan plc., Amgen Inc., Asahi Kasei Corporation, Dr. Reddy’s Laboratories, Daiichi Sankyo Company Limited, Eli Lilly and Company, EffRx Pharmaceuticals SA, F Hoffmann La Roche AG, GlaxoSmithKline Plc., Mylan Inc., Merck & Co AG, Novartis AG, Pfenex Inc., Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
Global Osteoporosis Treatment Market: Key Takeaways
Major players operating in the global osteoporosis treatment market are focused on approval and launch of new products to enhance their market share. For instance, in 2017, the U.S Food and Drug Administration approved YMLOS (abaloparatide) injection from Radius Health, Inc. for the treatment of postmenopausal women with osteoporosis.
𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/1096
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- PEST Analysis
- Pipeline Analysis
- Product Approval
- Product Launch
- Collaboration-Acquisition
- Porter’s Five Forces Analysis
- Market Dynamics
- Global Osteoporosis Treatment Market, By Drug Type, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Bisphosphonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Segment Trends
- Alendronate
- Risedronate
- Ibandronate
- Zoledronic Acid
- Others
- Calcitonin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Hormone Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Selective Estrogen Receptor Modulators (SERMs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Parathyroid Hormone-Related Protein (PTHrP) Analog
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Rank Ligand (RANKL) Inhibitor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Osteoporosis Treatment Market, By Route of Administration, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
- Global Osteoporosis Treatment Market, By Distribution Channel, 2016 – 2026 (US$ Bn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Bn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/osteoporosis-treatment-market-to-surpass-us-166-bn-threshold-by-2026-1063
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837